Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of OKI-179 as a Single Agent in Patients With Advanced Solid Tumors

NCT03931681 is registered in ClinicalTrials.gov with OnKure, Inc. as lead sponsor.

NCT NCT03931681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03931681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of OKI-179 as a Single Agent in Patients With Advanced Solid Tumors
Lead sponsor
OnKure, Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 8, 2019
Completion date
November 27, 2021
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors